Filing Flows › Chemours (CC) › Q1 2026
Chemours (CC) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 5, 2026
Chemours (CC) reported revenue of $1.4B for the first quarter 2026 (Q1 2026), +1% from a year earlier and +4% from the quarter before. Operating margin was -1.6%, net loss $29.0M (2.1% of revenue).
Chemours, Q1 2026: revenue $1.4B (+1% year over year), operating margin -1.6%, net loss $29.0M, operating cash flow −$44.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4B | +4% | +1% |
| Operating profit | −$22.0M | — | — |
| Net earnings | −$29.0M | — | — |
| Operating cash flow | −$44.0M | -132% | — |
What changed
Revenue was $1.4B in Q1 2026, up 1% year over year and up 4% from the previous quarter. All Segments was the largest line at 99% of revenue. All Segments added $0.01B year over year (up 1%), 100% of the total change.
Gross margin was 15.4%, down 1.9 points from Q1 2025. Operating costs exceeded revenue by $0.02B, an operating margin of -1.6%. Operating expenses fell 1% while revenue rose 1%. The fastest-growing cost line was SG&A (+20%). The quarter ended with a net loss of $0.03B, narrower than the previous quarter's $0.05B loss.
Operating cash flow was −$0.04B. Non-cash charges added back $0.08B of depreciation and $0.01B of share-based compensation. Working capital and other items used $0.10B. Capital expenditures of $0.05B exceeded it, leaving free cash flow of −$0.09B.
Questions
What was Chemours' revenue in the first quarter 2026?
Chemours (CC) reported revenue of $1.4B for the first quarter 2026 (Q1 2026), +1% from a year earlier and +4% from the quarter before.
Was Chemours profitable in the first quarter 2026?
Operating loss was $22.0M (-1.6% of revenue) and net loss $29.0M.
Source: Chemours 10-Q on SEC EDGAR.